药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Methylphenobarbital
Fluocortin
The risk or severity of adverse effects can be increased when Docetaxel is combined with Fluocortin.
Methylphenobarbital
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Docetaxel is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Methylphenobarbital
Hypericin
The risk or severity of adverse effects can be increased when Docetaxel is combined with Hypericin.
Methylphenobarbital
Acteoside
The risk or severity of adverse effects can be increased when Docetaxel is combined with Acteoside.
Methylphenobarbital
Deoxyspergualin
The risk or severity of adverse effects can be increased when Docetaxel is combined with Deoxyspergualin.
Methylphenobarbital
Doxifluridine
The risk or severity of adverse effects can be increased when Docetaxel is combined with Doxifluridine.
Methylphenobarbital
Trofosfamide
The risk or severity of adverse effects can be increased when Docetaxel is combined with Trofosfamide.
Methylphenobarbital
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Docetaxel is combined with Cepeginterferon alfa-2B.
Methylphenobarbital
Gusperimus
The risk or severity of adverse effects can be increased when Docetaxel is combined with Gusperimus.
Methylphenobarbital
Mizoribine
The risk or severity of adverse effects can be increased when Docetaxel is combined with Mizoribine.
Methylphenobarbital
Ozanimod
The risk or severity of adverse effects can be increased when Docetaxel is combined with Ozanimod.
Methylphenobarbital
Triptolide
The risk or severity of adverse effects can be increased when Docetaxel is combined with Triptolide.
Methylphenobarbital
Guselkumab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Guselkumab.
Methylphenobarbital
Sirukumab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Sirukumab.
Methylphenobarbital
Brodalumab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Brodalumab.
Methylphenobarbital
Peficitinib
The risk or severity of adverse effects can be increased when Docetaxel is combined with Peficitinib.
Methylphenobarbital
Voclosporin
The risk or severity of adverse effects can be increased when Docetaxel is combined with Voclosporin.
Methylphenobarbital
Pirarubicin
The risk or severity of adverse effects can be increased when Docetaxel is combined with Pirarubicin.
Methylphenobarbital
Ravulizumab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Ravulizumab.
Methylphenobarbital
Ixekizumab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Ixekizumab.